BioScrip, Inc. Announces Opening of Two New Specialty Pharmacies.ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS BIOS in full Basic Input/Output System Computer program that is typically stored in EPROM and used by the CPU to perform start-up procedures when the computer is turned on. ) today announced the opening of new specialty pharmacies in Hawthorne, New York Hawthorne is an unincorporated hamlet and census-designated place (CDP) located in the town of Mount Pleasant in Westchester County, New York. The population was 7,083 at the 2000 census. History Much of Hawthorne was once known as Sherman Park. , and Pompano Beach, Florida Pompano Beach is a city in Broward County, Florida, along the coast of the Atlantic Ocean just to the north of Fort Lauderdale. The Nearby Hillsboro Inlet forms part of the Atlantic Intracoastal Waterway. As of 2006, the U.S. . The New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of location, situated on the campus of Westchester Medical Center, will offer convenient access to specialty and traditional medications to the more than 3.5 million people in NY's Hudson Valley
The Hudson Valley refers to the canyon of the Hudson River and its adjacent communities in New York State, generally from northern Westchester County northward to the cities of Albany and Troy. region and beyond that the Medical Center serves. In addition, a new infusion pharmacy and treatment site in Pompano Beach, Florida, has been completed and will be operational by the end of January, 2008. BioScrip now has seven pharmacy locations throughout the State of Florida. Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Richard H. Friedman, stated, "We continue to look to expand our pharmacy services across the country in select growth markets based on population, payor mix and current business. These two new locations will provide increased access to medications and services for patients and help strengthen our market position as we continue to execute on our strategic initiatives." In addition, as permitted by Section 4350(i)(1)(iv) of the NASDAQ listing requirements Listing requirements Requirements, including minimum shares outstanding, market value, and income, that are laid down by an exchange for any stock to be listed for trading. , the Company has made equity-based compensation awards outside of its stockholder approved equity-based plans to the following employees: (i) Mr. Richard T. Goldsby, Director of Information Technology was granted 20,000 options to purchase common stock, par value $0.001 per share ("Common Stock"), and 12,000 restricted shares of the Company's Common Stock ("Restricted Shares"), and (ii) Mr. James Daddio and Ms. Sandra Johnson, both Directors of National Accounts were granted 15,000 options and 8,500 Restricted Shares. The above grants vest over three years in equal annual installments. The exercise price of all options granted was the closing stock price on the date of approval by BioScrip's Management Development and Compensation Committee. About BioScrip, Inc. BioScrip, Inc. (www.bioscrip.com) (Nasdaq: BIOS) is a specialty pharmaceutical health care organization that partners with patients, physicians, health care payors and pharmaceutical manufacturers to provide access to medications and management solutions to optimize optimize - optimisation outcomes for chronic and other complex health care conditions. Forward Looking Statements This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion